Long-term risk of relapse in immune-mediated thrombotic thrombocytopenic purpura and the role of anti-CD20 therapy.

Doyle, Andrew J; Stubbs, Matthew J; Dutt, Tina; Lester, Will; Thomas, Will; van Veen, Joost; Hermans, Joannes; Cranfield, Tanya; Hill, Quentin A; Clark, Amanda; Bagot, Catherine; Austin, Steven; Westwood, John-Paul; Thomas, Mari; Scully, Marie

Doyle, Andrew J; Stubbs, Matthew J; Dutt, Tina; Lester, Will; Thomas, Will; van Veen, Joost; Hermans, Joannes; Cranfield, Tanya; Hill, Quentin A; Clark, Amanda; Bagot, Catherine; Austin, Steven; Westwood, John-Paul; Thomas, Mari; Scully, Marie.

Afiliación

Doyle AJ; University College London Hospitals NHS Foundation Trust, London, United Kingdom.
Stubbs MJ; Guy's and St Thomas's NHS Foundation Trust, London, United Kingdom.
Dutt T; University College London Hospitals NHS Foundation Trust, London, United Kingdom.
Lester W; Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom.
Thomas W; University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.
van Veen J; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
Hermans J; Sheffield Teaching Hospitals NHS Trust, Sheffield, United Kingdom.
Cranfield T; Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.
Hill QA; Portsmouth Hospitals University NHS Trust, Portsmouth, United Kingdom.
Clark A; Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.
Bagot C; University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom.
Austin S; NHS Greater Glasgow and Clyde, Glasgow, United Kingdom.
Westwood JP; Guy's and St Thomas's NHS Foundation Trust, London, United Kingdom.
Thomas M; St George's University Hospitals NHS Foundation Trust, London, United Kingdom.
Scully M; University College London Hospitals NHS Foundation Trust, London, United Kingdom.

Blood ; 141(3): 285-294, 2023 01 19.

Article en En | MEDLINE | ID: mdl-36322971

Asunto(s)

Púrpura Trombocitopénica Trombótica; Humanos; Rituximab/uso terapéutico; Púrpura Trombocitopénica Trombótica/terapia; Proteína ADAMTS13; Recurrencia; Reino Unido/epidemiología

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Púrpura Trombocitopénica Trombótica Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Blood Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google